About Us - Overview

Emisphere, a biopharmaceutical company, has developed a broad-based proprietary drug delivery platform called the Eligen^® Technology. Emisphere's Eligen^® Technology improves the body's ability to absorb select molecules. Emisphere's carriers provide a demonstrated safe method of chaperoning molecules without affecting their biological benefit. Many of these molecules are currently delivered by injection, such as salmon calcitonin; in certain cases, their benefits are limited due to poor bioavailability, slow onset of action, or variable absorption, such as Vitamin B12. The Eligen^® Technology can be applied to the oral route of administration as well other delivery pathways, such as buccal, rectal, inhalation, intra-vaginal or transdermal.

Emisphere's Eligen^® delivery system can enhance overall healthcare, including patient accessibility and compliance, while benefiting the commercial pharmaceutical marketplace and driving Company valuation.